(Q44461620)

English

Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

apoptotic process

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Dylan T Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kanagasabai Ganeshaguru

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Wayne A Mitchell

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Letizia Foroni

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Robert J Baker

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

H Grant Prentice

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Atul B Mehta

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

R Gitendra Wickremasinghe

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

713-720

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

The biochemistry of apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

CD95's deadly mission in the immune system

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

From bench to clinic with apoptosis-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

BID regulation by p53 contributes to chemosensitivity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Steering anti-cancer drugs away from the TRAIL

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04340.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2003.04340.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44461620&oldid=2024796489"